Literature DB >> 24454592

PEComa of soft tissues can mimic lymph node relapse in patients with history of testicular seminoma.

Gabriele Guglielmetti1, Paolo De Angelis1, Paolo Mondino1, Carlo Terrone1, Alessandro Volpe1.   

Abstract

Perivascular Epithelioid Cell tumour (PEComa) is rare. We describe a 39-year-old man who underwent a left radical orchidectomy and adjuvant radiation therapy for a stage IA classical testicular seminoma. He was diagnosed with a mass lateral to the right common iliac artery that was considered suspicious for late lymph node relapse after 3 years of follow-up. Due to the unusual location of the mass and the equivocal findings of percutaneous biopsy, a laparoscopic pelvic lymphadenectomy was performed. Final pathology revealed PEComa of soft tissue. The patient is disease-free after 38 months of follow-up without adjuvant treatment. The presence of rare soft-tissue neoplasm should be considered in differential diagnosis of retroperitoneal masses during follow-up of germ cell tumours. Suspicious isolated recurrences of these neoplasms in unusual locations can require surgical excision to confirm diagnosis and avoid inappropriate treatment.

Entities:  

Year:  2013        PMID: 24454592      PMCID: PMC3894656          DOI: 10.5489/cuaj.413

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  9 in total

Review 1.  Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.

Authors:  Andrew L Folpe; Thomas Mentzel; Hans-Anton Lehr; Cyril Fisher; Bonnie L Balzer; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

Review 2.  Perivascular epithelioid cell neoplasms: pathology and pathogenesis.

Authors:  Andrew L Folpe; David J Kwiatkowski
Journal:  Hum Pathol       Date:  2009-07-15       Impact factor: 3.466

Review 3.  Late relapse of testicular germ cell tumors.

Authors:  Brett S Carver; Robert J Motzer; Gnanamba Varuni Kondagunta; Pramod G Sogani; Joel Sheinfeld
Journal:  Urol Oncol       Date:  2005 Nov-Dec       Impact factor: 3.498

4.  Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa.

Authors:  A Italiano; C Delcambre; I Hostein; A L Cazeau; M Marty; A Avril; J-M Coindre; B Bui
Journal:  Ann Oncol       Date:  2010-03-09       Impact factor: 32.976

5.  Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.

Authors:  Mikhail Fedyanin; Alexey Tryakin; Dheepak Kanagavel; Anatoly Bulanov; Alena Burova; Konstantin Figurin; Igor Fainshtein; Uriy Sergeev; Tatiana Zakharova; August Garin; Sergei Tjulandin
Journal:  Urol Oncol       Date:  2011-07-30       Impact factor: 3.498

6.  Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.

Authors:  Heidi Kenerson; Andrew L Folpe; Thomas K Takayama; Raymond S Yeung
Journal:  Hum Pathol       Date:  2007-05-22       Impact factor: 3.466

7.  "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Sarcoma       Date:  2012-04-26

Review 8.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

9.  Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis.

Authors:  Oluwole Fadare; Vinita Parkash; Yesim Yilmaz; M Rajan Mariappan; Linglei Ma; Denise Hileeto; Mazin B Qumsiyeh; Pei Hui
Journal:  World J Surg Oncol       Date:  2004-10-19       Impact factor: 2.754

  9 in total
  1 in total

1.  Retroperitoneal perivascular epithelioid cell tumours: A case report and review of literature.

Authors:  Zisis Touloumis; Niki Giannakou; Christos Sioros; Argiro Trigka; Maria Cheilakea; Nikoletta Dimitriou; John Griniatsos
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.